Literature DB >> 1651875

Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy.

L M Fang1, W Osterrieder.   

Abstract

Ro 40-5967 is a structurally novel Ca2+ channel blocker which binds to the [3H]desmethoxyverapamil receptor in cardiac membranes with a potency similar to that of verapamil but which has considerably fewer negative inotropic effects. In the present study, the inward Ca2+ current was measured in isolated myocytes with the whole-cell patch-clamp technique. It was found that at a physiological membrane potential (-80 mV) Ro 40-5967 was also less potent than verapamil in inhibiting this current, and that negative inotropy and Ca2+ channel blockade were correlated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651875     DOI: 10.1016/0014-2999(91)90430-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD.

Authors:  B M Massie; S G Chrysant; A Jain; M Weir; R Weiss; I Korrin
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

2.  Pentobarbital inhibition of human recombinant alpha1A P/Q-type voltage-gated calcium channels involves slow, open channel block.

Authors:  A Schober; E Sokolova; K J Gingrich
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

3.  Effects of mibefradil on intracellular Ca2+ release in cultured rat cardiac fibroblasts and human platelets.

Authors:  M Eberhard; K Miyagawa; K Hermsmeyer; P Erne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

Review 4.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

Review 5.  Management of calcium channel antagonist overdose.

Authors:  Steven D Salhanick; Michael W Shannon
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Expression of the L-type calcium channel with two different beta subunits and its modulation by Ro 40-5967.

Authors:  A Welling; L Lacinova; K Donatin; A Ludwig; E Bosse; V Flockerzi; F Hofmann
Journal:  Pflugers Arch       Date:  1995-01       Impact factor: 3.657

7.  The interaction of the calcium antagonist RO 40-5967 with digoxin.

Authors:  M Siepmann; C Kleinbloesem; W Kirch
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.